IRIS: Case Studies & Articles

 


  

IRIS Raises Series B Growth Funding

Intelligent Retinal Imaging Systems, a leader in early detection systems for diabetic eye disease, announced today that they have closed a round a Series B growth funding. Led by Tampa-based Ballast Point Ventures, this investment will be used to support the company's expansion and growth strategy, as well as support IRIS's goal of developing the next generation of products that detect eye disease and improve the monitoring and care of patients in diabetic populations. Outside of M&A, investment transactions in healthcare IT are rare with only about 70 happening each year. As part of their growth strategy, IRIS will be focused on recruiting Pensacola-based talent and investing in a complete remodel of its headquarters location to accommodate the expected growth in staff. This event markes a huge milestone in the company's evolution as the industry leader for early detection systems for diabetic eye disease.

 

Read More »

   


 

Using Telemedicine to Prevent Blindness

The number of patients diagnosed with diabetes in West Virginia is reaching epidemic levels. Diabetic retinopathy (DR) is the leading cause of preventable blindness in working-age adults and in the diabetic population. At current rates, one in three Americans with diabetes will have diabetic retinopathy by 2050. To help prevent this projection from becoming a reality, West Virginia University (WVU) and the West Virginia Practice-Based Research Network (WVPBRN) partnered with IRIS to implement a diabetic retinopathy telemedicine evaluation program at a handful of primary care locations across the state.

 

Read More »

  


  

Microsoft's Vision for Digital Transformation in Health

Explore how Microsoft technology is improving global health through a digital transformation in the health industry - featuring IRIS and our CEO, Jason Crawford, to explain how we are innovating eye care delivery. 

 

 


Microsoft Innovation Awards recognize progress in retinal imaging, 3D visualization, and crowd-sourcing applications

In a ceremony at the Microsoft Global Health Forum at HIMSS 2017, IRIS, CoxHealth, Children’s Hospital of Los Angeles, and Children’s Mercy Hospital were among the teams recognized for their innovations in the delivery of healthcare. 

Read More »

 


IRIS and CoxHealth honored as recipients of the 2017 Microsoft Health Innovation Awards

IRIS – Intelligent Retinal Imaging Systems, in partnership with their customer CoxHealth Systems, has received a prestigious 2017 Microsoft Health Innovation Award for their diabetic retinal diagnostic solution. The awards, which were announced at the 2017 HIMSS Annual Conference and Exhibition, recognize health organizations and their technology solution partners for using Microsoft devices and services in innovative ways that help engage patients, empower care team, optimize clinical operational effectiveness, and transform the care continuum.

Read More »

 

Closing a significant care gap while achieving quality outcomes

For patients with diabetes, vision loss is preventable in 95% of cases. However, many health systems continue to struggle with ensuring their patients with diabetes get their annual diabetic retinopathy exams (DREs). This article for Becker’s Hospital Review, written by Dr. Mark Costley of CoxHealth, outlines how this organization, facing a DRE compliance rate of 32 percent in June 2016, has managed to close the gap by providing DREs through the health system’s primary care physicians.

Read More »

  


Innovations: Integrating diabetic eye screenings with primary care

In this article by Erica Teichert of Modern Healthcare, IRIS CEO Jason Crawford, CoxHealth medical director Dr. Mark Costley, and CoxHealth administrative director of regional services Brock Shamel discuss the value of providing digital retinal screenings to patients with diabetes through the primary care physician’s office. The CoxHealth system started using IRIS' technology in 15 of its 80 offices in mid-June, and has diagnosed 291 patients with diabetic retinopathy so far. Before CoxHealth introduced eye exams into its primary care visits, only 32% to 38% of its patients with diabetes were going to specialists to get the test.

Read More »

  


Adding Teleretinal Exams to the EHR is Time and Sight Saving

Diabetic retinopathy is the most common cause of vision loss among people with diabetes, but early detection can reduce the risk of severe vision loss by 90%. Sustainable, EHR-integrated teleretinal screenings not only saves time, it can save sight for millions of patients with Retinopathy. In the popular blog for physicians, The Doctor Weighs In, IRIS founder, Dr. Sunil Gupta, MD discusses the benefits of integrating teleretinal screenings into the every day workflow. Health Systems like Cox Health found that 18% of patients screened in the first six weeks of their program had undiagnosed diabetic retinopathy. After integrating IRIS’s stand-alone teleretinal examination program with their EHR, Harris Health System found 86% of their PCPs reported the integration increased access for their patients receiving DRE, and that there was a 69% decrease in the time it took to obtain results of the patient scan.

Read More »

  


CoxHealth Case Study

The Missouri-based health system, CoxHealth, is preventing blindness and closing the care gap in patients with diabetes by providing eye exams in the primary care environment.  Rapid improvement has been achieved in HEDIS Quality Measures with the IRIS diabetic retinopathy telemedicine solution.  CoxHealth administered the diabetic retinopathy exam (DRE) to 1,040 patients over the initial six-week period, diagnosing 150 (18%) with diabetic retinopathy who otherwise would have gone undiagnosed. Of the 150 patients diagnosed with diabetic retinopathy, 136 were found to have non-proliferative diabetic retinopathy and 14 were given proliferative, vision-threatening diagnoses.

Read More »

  


  

Most Diabetic Patients Favor Telehealth Eye Exams, Survey Finds

Until now, little has been known about patients’ attitudes toward telemedicine for diabetic retinopathy. While telemedicine is just as safe and effective as in-person exams for monitoring diabetic eye disease, it’s not clear whether older adults are open to these kinds of services. Maria Woodward, MD, assistant professor of ophthalmology at the University of Michigan’s Kellogg Eye Center, and her colleagues conducted a study of older adults to find out if they would be receptive to telehealth-based exams.

Read More »

  


 

A Vision of Hope for Diabetic Retinopathy Patients

In this article by Joe Cantlupe for HealthDataBuzz, Dr. Sunil Gupta, founder of IRIS, discusses his mission to drastically improve eye care and how IRIS Is achieving this goal. Through partnerships with independent physicians, healthcare systems, insurers and others, at least 110,000 otherwise unexamined diabetic patients have received retinal exams. The IRIS team has made the workflow easy and efficient for physicians by developing bi-directional data integrations with multiple EHRs including EPIC.

Read More »

 


 

A Population-Health Approach to Preventing Blindness

Published in Becker's Hospital Review, April 2016
Improved access, increased quality, and decreased cost. In short, it's the Triple Aim as defined by the Institute for Healthcare Improvement (IHI) and the goal of forward-thinking health systems nationwide.

It is also the initiative that can leave healthcare executives asking, "how do we actually achieve this?" But when it comes to a growing and significant population – diabetics – and the ability to prevent something as life altering as blindness, the "how" can be easier than most realize.

Read More »

 


 

Telemedicine and Retinal Imaging:  One Step Closer to Ending Preventable Blindness

Published in Advanced Ocular Care, February 2016
When a standard method of operations is used, the performance of teleretinal examinations in primary care settings can be an efficient and streamlined process. This has been demonstrated at the Harris Health System in Houston, Texas. Harris Health System. In the first 12 months after implementation of the IRIS teleretinal imaging program, we at Harris Heath/Baylor College of Medicine, have conducted more than 18,000 exams and raised the examination rate from well below 50% to greater than 80%. 

Read More »

 


 

Evaluation of Automated Teleretinal Screening Program for Diabetic Retinopathy

From JAMA Ophthalmology, February 2016
The IRIS computer algorithm-based screening program had a high sensitivity and a low false–negative rate, suggesting that it may be an effective alternative to conventional reading center image interpretation. The IRIS algorithm shows promise as a screening program, but algorithm refinement is needed to achieve better performance. Further studies of patient safety, cost-effectiveness, and widespread applications of this type of algorithm should be pursued to better understand the role of teleretinal imaging and automated analysis in the global health care system.

Read More » 

 


 

Policy Recommendations to Guide the Use of Telemedicine in Primary Care Settings

Diabetic retinopathy is the leading cause of blindness in the working population of the United States. The unequivocal recommendation for all diabetics is an annual retinal screening exam, according to the American Academy of Ophthalmology, the American Diabetes Association, retinal specialists and primary care physicians. Despite the earnest advice, just half of patients who need retinal exams follow through on the recommendation.

Read More » 

 


 

Telemedicine for Long-term Surveillance of Diabetic Retinopathy

Diabetic retinopathy is the leading cause of blindness in the working population of the United States. The unequivocal recommendation for all diabetics is an annual retinal screening exam, according to the American Academy of Ophthalmology, the American Diabetes Association, retinal specialists and primary care physicians. Despite the earnest advice, just half of patients who need retinal exams follow through on the recommendation.

Read More »

 


 

Telehealth Practice Recommendations For Diabetic Retinopathy

This comprehensive document, produced by the American Telemedicine Association, provides suggestions to help improve clinical outcomes and promote reasonable patient and care provider expectations.

Read More »

 


 

Telemedicine & Ocular Health In Diabetes Mellitus

This study provides insight into how teleretinal programs that use existing infrastructure solutions for people with diabetes increase access to and adherence to appropriate eye care.

Read More »

 


 

Harris Health System Case Study

Harris Health System in Houston, TX installed IRIS cameras in 8 of their busiest primary care practices throughout the county. Within one week, they went live at each location, taking a clinical exam previously performed by a specialist down to an automated exam performed by a patient care technician (PCT). 

Read More »

 


 

2014 IDF Diabetes Atlas

A great infographic and data table detailing facts about diabetes worldwide.  Outlines the prevalance of diabetes, both diagnosed and undiagnosed.

Read More »

 


 

Improving Diabetic Retinopathy Screening Rates Using Telemedicine

Evaluates the impact of a telemedicine, digital retinal imaging strategy on diabetic retinopathy screening rates in an inner-city primary care clinic.

Read More »

 


 

The Cost Of A Community-Based Screening Program

Very few retinopathy screening studies have been conducted in community settings. This is a study determining the costs of a community-based program to screen adults for diabetic retinopathy.

Read More »

 


 

The Sensitivity & Specificity Of Telemedicine In Detecting Diabetic Retinopathy

The objective of this study was to determine the sensitivity of the nonmydriatic digital stereoscope retinal imaging (NMDSRI) as a screening tool in detecting diabetic retinopathy.

Read More »

Get IRIS Updates: